Optic neuritis after in Xiximab therapy

Rheumatology International

Volumn 33, Issue 4, 2013, Pages 1101-1103

  Faillace, César ^a   De Almeida, João Ricardo Maltez ^b   De Carvalho, Jozélio Freire ^a  

^a Clinica de Oncologia CLION   (Brazil)

^b Radiology Division   (Brazil)

Author keywords

Anti TNF; Demyelinating disease; InXiximab; Neuritis optica

Indexed keywords

ADALIMUMAB; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALGORITHM; ARTICLE; BLINDNESS; BLURRED VISION; CASE REPORT; CLINICAL ARTICLE; DEMYELINATING DISEASE; DRUG WITHDRAWAL; FEMALE; HEMIANOPIA; HUMAN; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGIST; OPTIC NERVE; OPTIC NEURITIS; ORBIT; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VISUAL ACUITY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; LETTER;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; OPTIC NEURITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886605570     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2316-x     Document Type: Article

References (21)

1. Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsiks P et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 36: 1681-1690
2. Furst DE (2010) The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 39: 327-346
3. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534
4. Thomas CW Jr, Weinshenker BG, Sandborn WJ (2004) Demyelination during anti-tumor necrosis factor alpha therapy with inXiximab for Crohn's disease. InXamm Bowel Dis 10: 28-31
5. Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54: 1429-1434
6. Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inXammatory arthritides. Arthritis Rheum 44: 2862-2869
7. Foroozan R, Buono LM, Sergott RC, Savino PJ (2002) Retrobulbar optic neuritis associated with inXiximab. Arch Ophthalmol 120: 985-987
8. Mejico LJ (2004) InXiximab-associated retrobulbar optic neuritis. Arch Ophthalmol 122: 793-794
9. Strong BY, Erny BC, Herzenberg H, Razzeca KJ (2004) Retrobulbar optic neuritis associated with inXiximab in a patient with Crohn disease. Ann Intern Med 140:W34
10. Chan JW, Castellanos A (2010) InXiximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol 248: 283-287
11. Felekis T, Katsanos K, Christodoulou D, Asproudis I, Tsianos EV (2009) Reversible bilateral optic neuritis after InXiximab discontinuation in a patient with Crohn's disease. J Crohns Colitis 3:212- 214
12. Ouakaa-Kchaou A, Gargouri D, Trojet S, Hefaiedh R, Elloumi H, Kochlef A, Kilani A, Romani M, Kharrat J, Ghorbel A (2009) Retrobulbar optic neuritis associated with inXiximab in a patient with Crohn's disease. J Crohns Colitis 3: 131-133
13. Pikkel J (2008) Possible link between inXiximab and optic neuritis. Isr Med Assoc J 10: 477-478
14. Hejazi R, Colombel JF, Peyrin-Biroulet L (2008) Retrobulbar optic neuritis during inXiximab treatment for ulcerative colitis. Gastroenterol Clin Biol 32: 162-163
15. Mumoli N, Niccoli G, Scazzeri F, Picchietti S, Greco A, Cei M (2007) InXiximab-induced retrobulbar optic neuritis. QJM 100:531
16. Simsek I, Erdem H, Pay S, Sobaci G, Dinc A (2007) Optic neuritis occurring with anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 66: 1255-1258
17. Bidaguren A, Müller-Thyssen A, Blanco A, Mendicute J, Ubeda M (2007) Retrobulbar optic neuritis associated with InXiximab. Arch Soc Esp Oftalmol 82: 109-112
18. Tran TH, Milea D, Cassoux N, Bodaghi B, Bourgeois P, LeHoang P (2005) Optic neuritis associated with inXiximab. J Fr Ophtalmol 28: 201-204
19. Rebolleda G (2004) Optic neuritis and inXiximab. Arch Soc Esp Oftalmol 79:591
20. Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol InXamm 18: 475-481
21. Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44: 1977-1983